about
Changing treatment patterns for coronary artery revascularization in Canada: the projected impact of drug eluting stentsRegulations and policies regarding e-cigarettesThe burden of age-related macular degeneration.The impact of candidemia on length of hospital stay, outcome, and overall cost of illness.Clinical management of smoking cessation: patient factors affecting a reward-based approachEconomics in epilepsy treatment choices: our certain fate?Levalbuterol compared to racemic albuterol: efficacy and outcomes in patients hospitalized with COPD or asthma.The health care experience of patients with cancer during the last year of life: Analysis of the SEER-CAHPS data set.The economic implications of glaucoma: a literature review.Evaluation of costs for cystoid macular edema among patients after cataract surgery.Impact of insurance status on access to care and out-of-pocket costs for U.S. individuals with epilepsy.Factors influencing the desire to provide MS patient care in clinical practice among physiatrists.Factors associated with colon cancer stage at diagnosis.Racial and ethnic disparities in smoking-cessation interventions: analysis of the 2005 National Health Interview Survey.Cost-effectiveness of cesarean section delivery to prevent mother-to-child transmission of HIV-1.Factors associated with immunotherapy use among newly diagnosed cancer patients.Factors predictive of survival in advanced laryngeal cancer.Impacts of a smoking cessation benefit among employed populations.Insurance status, health equity, and the cancer care continuum.Impact of clinical and non-clinical factors on the choice of HER2 test for breast cancer.Reasons for Underutilization of Bariatric Surgery: The Role of Insurance Benefit DesignInsurance Coverage and Preventive Care Among AdultsCancer disparities research: It is time to come of ageThe Relationship Between Insurance Coverage and Cancer Care: A Literature SynthesisPrevalence of Outpatient Cancer Treatment in the United States: Estimates from the Medical Panel Expenditures Survey (MEPS)Medical costs associated with alternative therapies for the treatment of gastroesophageal reflux diseaseEconomic assessment of the community-acquired pneumonia intervention trial employing levofloxacinHealth Care CBA and CEA from 1991 to 1996: An Updated BibliographyModulation of a human immunosuppressive lymphokine by monosaccharidesCare experiences among dually enrolled older adults with cancer: SEER-CAHPS, 2005-2013
P50
Q24803372-D5B2A94B-4235-457A-BE09-9785FF55DF66Q29994567-9DBED7AB-44CF-4182-AF53-EA5B0A023C77Q33239452-4946BAB7-EBBA-4A94-8DFF-866DD50DDA1AQ34478125-11B3CC97-320B-4CB9-A717-F0FC3ADB0BA8Q34555146-477B3820-A0DA-469D-9CF1-A38E91233A3CQ34680666-142045B3-9DE6-4BDF-B753-E39937D6C327Q35044928-B5B417B5-2637-4F65-8148-EC12EE5A1462Q36139825-679BA9F8-5862-485C-9626-1C83D98B8FAAQ36777803-DC1854B5-96B2-4A12-B295-E72C3294EC96Q36844670-65E6FAB0-CF5C-41AF-ABAE-8C637D48B11CQ39710862-F2BD2D3A-CF07-422E-9CEE-419F8A1C03A4Q40902046-46F1BA1C-FEEE-411E-A10B-3256A99D2D04Q43617105-F239A9BA-B684-48C1-9446-42E0E61DF980Q43781139-21BB4D3E-78C6-4248-92E3-166E40E4D396Q44683703-9DD98036-B88F-4714-8033-0299695F9D5FQ44686681-0E540C16-0D03-4B5C-9583-4411D3A6A694Q44835834-63F121DA-A186-42B9-9253-FBB9173A9B5DQ44926098-77A1E1DB-738A-456B-B10E-E857FC4925D7Q48123837-F47437E6-04EC-4F60-9E6D-6D4FE43E7D22Q54665672-9C16083E-9D02-4AD5-8B38-A83C550EA15DQ57991257-377CFF6D-A443-4DF0-83FF-22A00B01BF8DQ57991265-20C26FF1-3BD3-4AB8-AA2C-2F2FE7B46CDAQ57991268-A06FAEA2-E6D9-4301-9D90-06E71E88AF0CQ57991274-1D7B5DC3-E9C1-46EC-A9F5-CB47FC47C763Q57991279-AA54420C-3BC1-4D19-B05E-039D5F25A24BQ57991295-05F0A6F1-53A6-46E7-8171-7D5D1F7CD0F7Q57991308-EBA5EED4-8382-4A4D-898B-02BE39686A7DQ57991313-D666EFC8-07BD-4D2C-B1EF-715D79870DC5Q57991317-810B1EBC-41F8-4E30-B64A-2BADE0A092D3Q92679319-2753EB75-58C9-40C0-A7A2-380B5F4DEF5A
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Michael T Halpern
@sl
Michael T. Halpern
@en
Michael T. Halpern
@es
Michael T. Halpern
@fr
Michael T. Halpern
@nl
type
label
Michael T Halpern
@sl
Michael T. Halpern
@en
Michael T. Halpern
@es
Michael T. Halpern
@fr
Michael T. Halpern
@nl
altLabel
Michael Halpern
@en
Michael Halpern
@fr
Michael T Halpern
@en
Michael T Halpern
@fr
prefLabel
Michael T Halpern
@sl
Michael T. Halpern
@en
Michael T. Halpern
@es
Michael T. Halpern
@fr
Michael T. Halpern
@nl
P244
P106
P214
19154739891252992380
P244
n2019180153
P31
P496
0000-0001-8514-6313
P734
P735
P7859
lccn-n2019180153